Last update 17 Jul 2024

Zuberitamab

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
Zebituzumab, Zuberitamab, 重组人-鼠嵌合抗CD20单克隆抗体 (海正药业)
+ [3]
Target
Mechanism
CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects), Complement dependent cytotoxicity (CDC) effects
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view First Approval Timeline

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
CD20 positive Diffuse Large B-Cell Lymphoma
CN
12 May 2023
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Purpura, Thrombocytopenic, IdiopathicPhase 2
CN
28 Oct 2021
Diffuse Large B-Cell LymphomaPhase 2
CN
03 Jan 2017
Diffuse Large B-Cell LymphomaPhase 2
CN
03 Jan 2017
CD20 positive Non-Hodgkin LymphomaPhase 2
CN
27 May 2016
CD20 positive Non-Hodgkin LymphomaPhase 2
CN
27 May 2016
Indolent Non-Hodgkin LymphomaPhase 2
CN
27 May 2016
Indolent Non-Hodgkin LymphomaPhase 2
CN
27 May 2016
CD20 Positive B-Cell Non-Hodgkin LymphomaPhase 1
CN
26 Feb 2015
CD20 Positive B-Cell Non-Hodgkin LymphomaPhase 1
CN
26 Feb 2015
Rheumatoid ArthritisIND Approval
CN
07 Nov 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
483
Zuberitamab plus CHOP
lxopoalcax(xhwdhtjydc) = ftjayzmvyg fyszkdzout (ygyjjolepy )
Positive
14 May 2024
Rituximab plus CHOP
lxopoalcax(xhwdhtjydc) = fguyssuhca fyszkdzout (ygyjjolepy )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free